Tivantinib
-
Catalog numberB1546-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_name(3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione; ARQ197
-
DescriptionTivantinib (ARQ-197) is a potent, cell-permeable inhibitor of c-Met with potential antineoplastic activity. Tivantinib binds to the c-Met protein and disrupts c-Met signal transduction pathways, which may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein.
-
CAS Number905854-02-6
-
Structure AvailableYes
-
Molecular FormulaC₂₃H₁₉N₃O₂
-
Molecular Weight369.41
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (~20 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA potent, cell-permeable inhibitor of c-Met with potential antineoplastic activity.
-
Storage Condition-20°C
-
Shipping ConditionGel Pack
-
Shelf Life36 months
-
PubChem CID11494412
-
SMILESC1CC2=CC=CC3=C2N(C1)C=C3C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65
-
InChiInChI=1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m0/s1
-
InChi KeyUCEQXRCJXIVODC-PMACEKPBSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameTivantinib
-
Alternative nameTivantinib
-
MeSH Data
-
Name
-
ConceptScope note: Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
-
Tree numbers
- E05.196.401.143
- E05.301.300.096
- E05.478.566.320.200
- E05.601.262
- E05.601.470.320.200
-
Qualifiersethics, trends, veterinary, history, classification, economics, instrumentation, methods, standards, statistics & numerical data